Press Releases from THELANSIS KNOWLEDGE PARTNERS LLP (1 total)
Idiopathic pulmonary fibrosis (IPF): Market Outlook and Competitive Landscape Re …
LAPS Triple Agonist (HM15211) of Hanmi Pharmaceutical has granted Orphan drug designation for treating Idiopathic pulmonary fibrosis (IPF). Pulmonary fibrosis occurs in the interstitium, which…
Go To Page:
